Numinus Wellness Inc. will host the clinics for the extension of the MAPS study.
Swiss study on MDMA looks at factors that influence a psychedelic response.
With MDMA, patients can revisit and process memories of traumatic experiences
Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder
Therapeutic breakthroughs suggest that the historical reputation of psychedelics as dangerous has unfairly overshadowed a more optimistic interpretation
Numinus Wellness chief medical officer Dr. Evan Wood cautions that it’s not a cure for everybody—but trials have shown statistically significant results
Clinical trials of MDMA psychotherapy are going on at 15 sites in the U.S., Canada, and Israel